Your browser doesn't support javascript.
loading
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.
Nishijima, Akira; Oda, Katsutoshi; Hasegawa, Kosei; Koso, Takahiro; Asada, Kayo; Ikeda, Yuji; Taguchi, Ayumi; Maeda, Daichi; Nagae, Genta; Tsuji, Shingo; Tatsuno, Kenji; Uehara, Yuriko; Kurosaki, Akira; Sato, Sho; Tanikawa, Michihiro; Sone, Kenbun; Mori, Mayuyo; Ikemura, Masako; Fujiwara, Keiichi; Ushiku, Tetsuo; Osuga, Yutaka; Aburatani, Hiroyuki.
  • Nishijima A; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Oda K; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Hasegawa K; Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. katsutoshi-tky@umin.ac.jp.
  • Koso T; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Asada K; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Ikeda Y; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Taguchi A; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Maeda D; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Nagae G; Department of Obstetrics and Gynecology, Nihon University, Tokyo, Japan.
  • Tsuji S; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Tatsuno K; Department of Molecular and Cellular Pathology, Kanazawa University, Ishikawa, Japan.
  • Uehara Y; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Kurosaki A; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Sato S; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Tanikawa M; Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
  • Sone K; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Mori M; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Ikemura M; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Fujiwara K; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Ushiku T; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Osuga Y; Department of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
  • Aburatani H; Department of Pathology, The University of Tokyo, Tokyo, Japan.
Sci Rep ; 14(1): 18797, 2024 08 13.
Article en En | MEDLINE | ID: mdl-39138354
ABSTRACT
The cellular origin of clear cell ovarian carcinoma (CCOC), a major histological subtype of ovarian carcinoma remains elusive. Here, we explored the candidate cellular origin and identify molecular subtypes using integrated genomic/epigenomic analysis. We performed whole exome-sequencing, microarray, and DNA methylation array in 78 CCOC samples according to the original diagnosis. The findings revealed that ARID1A and/or PIK3CA mutations were mutually exclusive with DNA repair related genes, including TP53, BRCA1, and ATM. Clustering of CCOC and other ovarian carcinomas (n = 270) with normal tissues from the fallopian tube, ovarian surface epithelium, endometrial epithelium, and pelvic peritoneum mesothelium (PPM) in a methylation array showed that major CCOC subtypes (with ARID1A and/or PIK3CA mutations) were associated with the PPM-lile cluster (n = 64). This cluster was sub-divided into three clusters (1) mismatch repair (MMR) deficient with tumor mutational burden-high (n = 2), (2) alteration of ARID1A (n = 51), and (3) ARID1A wild-type (n = 11). The remaining samples (n = 14) were subdivided into (4) ovarian surface epithelium-like (n = 11) and (5) fallopian tube-like (considered as high-grade serous histotype; n = 3). Among these, subtypes (1-3) and others (4 and 5) were found to be associated with immunoreactive signatures and epithelial-mesenchymal transition, respectively. These results contribute to the stratification of CCOC into biological subtypes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Factores de Transcripción / Adenocarcinoma de Células Claras / Metilación de ADN / Proteínas de Unión al ADN / Mutación Límite: Female / Humans / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Factores de Transcripción / Adenocarcinoma de Células Claras / Metilación de ADN / Proteínas de Unión al ADN / Mutación Límite: Female / Humans / Middle aged Idioma: En Año: 2024 Tipo del documento: Article